Skip to main content
logo
Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.8540
+0.0347 (4.24%)
Jul 29, 2026, 3:02 PM EDT - Market open

RANI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1061644686149322
Market Cap Growth
356.20%259.69%-47.20%-42.08%-53.69%-
Enterprise Value
62.04127.2649.2180.58118.12278.99
Last Close Price
0.851.351.373.325.9016.35

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
32.03100.5244.39--118.62
PB Ratio
2.884.9722.916.724.056.80
P/TBV Ratio
3.082.7119.586.583.816.74

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
19.5877.9347.87--102.69

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.073.790.960.390
Net Debt / Equity Ratio
-1.39-1.371.04-1.43-1.85-2.48
Net Debt / EBITDA Ratio
1.141.21-0.040.281.092.30
Net Debt / FCF Ratio
-2.41-0.060.351.423.59
Asset Turnover
0.060.030.02000.03
Quick Ratio
3.284.081.416.0820.4544.49
Current Ratio
3.404.211.506.3620.9645.30
Return on Equity (ROE)
-94.03%-181.98%-391.10%-136.52%-64.78%-1290.42%
Return on Assets (ROA)
-62.69%-80.44%-112.77%-79.66%-54.58%-50.64%
Return on Invested Capital (ROIC)
--4549.88%-848.54%-1037.74%-1286.92%-131.83%
Return on Capital Employed (ROCE)
-82.49%-122.21%-159.93%-86.33%-56.46%-52.74%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-238.89%-132.26%-11.65%-7.09%-21.93%58.34%
Total Shareholder Return
-238.89%-132.26%-11.65%-7.09%-21.93%58.34%
SEC Filings: 10-K · 10-Q